These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

901 related items for PubMed ID: 14982912

  • 1. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group.
    JAMA; 2004 Feb 25; 291(8):965-73. PubMed ID: 14982912
    [Abstract] [Full Text] [Related]

  • 2. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr 25; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 3. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Apr 25; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 25; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 5. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 25; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 6. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 25; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 7. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Jul 25; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul 25; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 9. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep 25; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 10. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
    Storey JR, Calder CS, Hart DE, Potter DL.
    Headache; 2001 Sep 25; 41(10):968-75. PubMed ID: 11903524
    [Abstract] [Full Text] [Related]

  • 11. Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.
    Freitag FG, Forde G, Neto W, Wang DZ, Schmitt J, Wu SC, Hulihan J.
    J Am Osteopath Assoc; 2007 Jul 25; 107(7):251-8. PubMed ID: 17682112
    [Abstract] [Full Text] [Related]

  • 12. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
    Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, Kurland CL, Nye J, Yuen E, Eerdekens M, Ford L.
    Pediatrics; 2009 Mar 25; 123(3):924-34. PubMed ID: 19255022
    [Abstract] [Full Text] [Related]

  • 13. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec 25; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 14. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
    Brandes JL, Kudrow DB, Rothrock JF, Rupnow MF, Fairclough DL, Greenberg SJ.
    Mayo Clin Proc; 2006 Oct 25; 81(10):1311-9. PubMed ID: 17036556
    [Abstract] [Full Text] [Related]

  • 15. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun 25; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 16. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
    Gupta P, Singh S, Goyal V, Shukla G, Behari M.
    Headache; 2007 Mar 25; 47(3):402-12. PubMed ID: 17371357
    [Abstract] [Full Text] [Related]

  • 17. Topiramate in migraine prevention.
    Silberstein SD.
    Headache; 2005 Apr 25; 45 Suppl 1():S57-65. PubMed ID: 15833091
    [Abstract] [Full Text] [Related]

  • 18. Time course of adverse events most commonly associated with topiramate for migraine prevention.
    Láinez MJ, Freitag FG, Pfeil J, Ascher S, Olson WH, Schwalen S.
    Eur J Neurol; 2007 Aug 25; 14(8):900-6. PubMed ID: 17662012
    [Abstract] [Full Text] [Related]

  • 19. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G, Diener HC, Pfeil J, Schwalen S.
    Int J Clin Pract; 2005 Aug 25; 59(8):961-8. PubMed ID: 16033621
    [Abstract] [Full Text] [Related]

  • 20. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.
    Cephalalgia; 2011 Jan 25; 31(1):18-30. PubMed ID: 20974598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.